Literature DB >> 25130693

The biology of Mur ligases as an antibacterial target.

Imène Kouidmi1, Roger C Levesque, Catherine Paradis-Bleau.   

Abstract

With antibiotic resistance mechanisms increasing in diversity and spreading among bacterial pathogens, the development of new classes of antibacterial agents against judiciously chosen targets is a high-priority task. The biochemical pathway for peptidoglycan biosynthesis is one of the best sources of antibacterial targets. Within this pathway are the Mur ligases, described in this review as highly suitable targets for the development of new classes of antibacterial agents. The amide ligases MurC, MurD, MurE and MurF function with the same catalytic mechanism and share conserved amino acid regions and structural features that can conceivably be exploited for the design of inhibitors that simultaneously target more than one enzyme. This would provide multi-target antibacterial weapons with minimized likelihood of target-mediated resistance development.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25130693     DOI: 10.1111/mmi.12758

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  16 in total

Review 1.  Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance.

Authors:  David A Dik; Jed F Fisher; Shahriar Mobashery
Journal:  Chem Rev       Date:  2018-05-30       Impact factor: 60.622

2.  The Canadian Institutes of Health Research response to antimicrobial resistance.

Authors:  E L Pagé; S Desnoyers; I J Létourneau; K Keown; A Jackson; M Ouellette
Journal:  Can Commun Dis Rep       Date:  2015-11-19

3.  Prospects for Antibacterial Discovery and Development.

Authors:  Thomas M Privalsky; Alexander M Soohoo; Jinhua Wang; Christopher T Walsh; Gerard D Wright; Eric M Gordon; Nathanael S Gray; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2021-12-03       Impact factor: 15.419

4.  Design, Synthesis, and Application of Carbon Dots With Synergistic Antibacterial Activity.

Authors:  Xingwang Qie; Minghui Zan; Ping Gui; Hongyi Chen; Jingkai Wang; Kaicheng Lin; Qian Mei; Mingfeng Ge; Zhiqiang Zhang; Yuguo Tang; Wen-Fei Dong; Yizhi Song
Journal:  Front Bioeng Biotechnol       Date:  2022-06-08

5.  Putative hexameric glycosyltransferase functional unit revealed by the crystal structure of Acinetobacter baumannii MurG.

Authors:  Kyoung Ho Jung; Sunghark Kwon; Chang Min Kim; Jun Hyuck Lee; Hyun Ho Park
Journal:  IUCrJ       Date:  2021-05-08       Impact factor: 4.769

Review 6.  Molecular mechanisms of vancomycin resistance.

Authors:  Peter J Stogios; Alexei Savchenko
Journal:  Protein Sci       Date:  2020-01-23       Impact factor: 6.725

7.  The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection.

Authors:  Madhab Sapkota; Ravi K R Marreddy; Xiaoqian Wu; Manish Kumar; Julian G Hurdle
Journal:  Anaerobe       Date:  2019-11-21       Impact factor: 3.331

8.  Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.

Authors:  Kandasamy Eniyan; Anuradha Kumar; Geetha Vani Rayasam; Andrej Perdih; Urmi Bajpai
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

9.  Structure of the essential peptidoglycan amidotransferase MurT/GatD complex from Streptococcus pneumoniae.

Authors:  Cécile Morlot; Daniel Straume; Katharina Peters; Olav A Hegnar; Nolwenn Simon; Anne-Marie Villard; Carlos Contreras-Martel; Francisco Leisico; Eefjan Breukink; Christine Gravier-Pelletier; Laurent Le Corre; Waldemar Vollmer; Nicolas Pietrancosta; Leiv Sigve Håvarstein; André Zapun
Journal:  Nat Commun       Date:  2018-08-09       Impact factor: 14.919

10.  Crystallographic Study of Peptidoglycan Biosynthesis Enzyme MurD: Domain Movement Revisited.

Authors:  Roman Šink; Miha Kotnik; Anamarija Zega; Hélène Barreteau; Stanislav Gobec; Didier Blanot; Andréa Dessen; Carlos Contreras-Martel
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.